Wednesday, 29 June 2011

Surgeons in Medtronic trials omitted results: report

NEW YORK (Reuters) - Surgeons conducting clinical trials to test a Medtronic Inc bone-growth protein used in spine surgery, some of whom got at least $62 million from the company, failed to report serious complications in their research papers, the Wall Street Journal reported.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/G9qI6NpUmVg/us-medtronic-idUSTRE75R7XC20110628

Skin Care Sleep Snoring Spa and Wellness Speech Pathology Supplements Thyroid

No comments:

Post a Comment